Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126503042 | 12650304 | 2 | F | 20160110 | 20160511 | 20160814 | 20160815 | EXP | US-TEVA-659822USA | TEVA | 38.63 | YR | F | Y | 66.01000 | KG | 20160815 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126503042 | 12650304 | 1 | PS | ADDERALL | AMPHETAMINE ASPARTATEAMPHETAMINE SULFATEDEXTROAMPHETAMINE SACCHARATEDEXTROAMPHETAMINE SULFATE | 1 | Oral | 40 MILLIGRAM DAILY; | U | 40422 | 20 | MG | BID | ||||||
| 126503042 | 12650304 | 2 | SS | BACLOFEN. | BACLOFEN | 1 | Oral | 30 MILLIGRAM DAILY; PRN | U | 72234 | 10 | MG | TABLET | TID | |||||
| 126503042 | 12650304 | 3 | SS | AMPYRA | DALFAMPRIDINE | 1 | Oral | 20 MILLIGRAM DAILY; | 0 | 10 | MG | TABLET | Q12H | ||||||
| 126503042 | 12650304 | 4 | C | ARMOUR THYROID | THYROID, PORCINE | 1 | Oral | 30 MILLIGRAM DAILY; | 0 | 30 | MG | QD | |||||||
| 126503042 | 12650304 | 5 | C | SERTRALINE | SERTRALINE HYDROCHLORIDE | 1 | Oral | 100 MILLIGRAM DAILY; | 0 | 100 | MG | QD | |||||||
| 126503042 | 12650304 | 6 | C | CLONAZEPAM. | CLONAZEPAM | 1 | Oral | .5 MILLIGRAM DAILY; PRN | 0 | .5 | MG | QD | |||||||
| 126503042 | 12650304 | 7 | C | TOPAMAX | TOPIRAMATE | 1 | Oral | 150 MILLIGRAM DAILY; | 0 | 50 | MG | TID | |||||||
| 126503042 | 12650304 | 8 | C | NUEDEXTA | DEXTROMETHORPHAN HYDROBROMIDEQUINIDINE SULFATE | 1 | Oral | 0 | Q12H |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126503042 | 12650304 | 1 | Fatigue |
| 126503042 | 12650304 | 2 | Multiple sclerosis |
| 126503042 | 12650304 | 3 | Multiple sclerosis |
| 126503042 | 12650304 | 4 | Hypothyroidism |
| 126503042 | 12650304 | 5 | Depression |
| 126503042 | 12650304 | 6 | Anxiety |
| 126503042 | 12650304 | 7 | Migraine |
| 126503042 | 12650304 | 8 | Multiple sclerosis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126503042 | 12650304 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126503042 | 12650304 | Product use issue | |
| 126503042 | 12650304 | Seizure |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126503042 | 12650304 | 3 | 20150415 | 0 |